Abstract
Clinical benefit from treatment with Iloprost in patients suffering from throm-boembolic disorders may arise from well known properties of the drug like inhibition of platelet aggregation, vasorelaxation, cytoprotection and stimulation of the plasma fibrinolytic activity [1–3]. Some, if not all, of these properties could qualify Iloprost as a drug with antithrombotic efficacy.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
References
Schrör K, Darius H, Matzky R, Ohlendorf R (1981) The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36374) equipotent to PGI2 in vitro. Naunyn-Schmiedebergs Arch Pharmacol 316: 252–255
Schrör K, Ohlendorf R, Darius H (1981) Beneficial effects of a new carbacyclin derivate, ZK 36374, in acute myocardial ischemia. J Pharmacol Exp Ther 219: 243–249
Korbut R, Byrska-Danek A, Gryglewski RJ (1983) Fibrinolytic activity of 6-keto-prostaglandin E1 Thromb Haemost 50: 493
Armstrong RA, Jones RL, Wilson NH (1983) The effect of thromboxane antagonism on aggregation and release in human platelets. Br J Pharmacol 78 [suppl]: 159 P
Menys VC, Davies JA (1983) Inhibitory effects of ZK 36 374, a stable prostacyclin analogue, on adhesion of rabbit platelets to damaged aorta and serotonin release by adherent platelets. Clin Sci 65: 149–153
Adaikan PG, Karim SMM, Lan LC, Tai MY, Kottegoda SR (1984) Inhibition of platelet aggregation and antagonism of vasopressin-induced ECG changes in primates by a carboprostacyclin analogue, ZK 36374. Thromb Res 33: 333–340
Smith GU, Duncan GG (1981) A study of intravascular platelet aggregation by continuous platelet counting. Thromb Res 23: 275–288
Van der Byl KV, Honour AJ, Leary WPP (1982) A method for the study of platelet “white body” formation in the mesenteric arteries of the living animal. Life Sci 31: 2985–2989
Schmidt R (1975) Eine neue Methode zur Erzeugung von Thromben durch Unterkühlung der Gefäßwand und ihre Anwendung zur Prüfung von Acetylsalicylsäure und Heparin. MD thesis, Justus Liebig University, Giessen
Meng K, Seuter F (1977) Effect of acetylsalicylic acid on experimentally induced arterial thrombosis in rats. Naunyn Schmiedebergs Arch Pharmacol 301: 115–119
Dejana E, Quintana A, Callioni A, Gaetano G de (1979) Bleeding time in laboratory animals. III — do tail bleeding times in rats only measure a platelet defect? (the aspirin puzzle). Thromb Res 15: 199–207
Baldus B, Müller B (1985) Iloprost improves the filtrability of stressed rabbit erythrocytes. 4th European conference on clinical haemorheology, Siena (abstract no 263 )
Baruche D, Hemker HC, Lindhout T (1985) Kinetic study of platelet factor V release and activation. Thromb Haemost 54: 130
Gryglewski RJ, Korbut R, Ocetkiewicz A (1978) De-aggregatory action of prostacyclin in vivo and its enhancement by theophylline. Prostaglandins 15: 637–644
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag, Berlin Heidelberg
About this paper
Cite this paper
Witt, W., Baldus, B., Müller, B. (1987). Antithrombotic Profile of Iloprost in Experimental Models of Arterial and Venous Thrombosis. In: Gryglewski, R.J., Stock, G. (eds) Prostacyclin and Its Stable Analogue Iloprost. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71499-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-71499-3_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71501-3
Online ISBN: 978-3-642-71499-3
eBook Packages: Springer Book Archive